MARKET

IBIO

IBIO

Ibio
AMEX
2.640
+0.190
+7.76%
After Hours: 2.690 +0.05 +1.89% 18:40 11/22 EST
OPEN
2.460
PREV CLOSE
2.450
HIGH
2.820
LOW
2.430
VOLUME
313.47K
TURNOVER
--
52 WEEK HIGH
6.12
52 WEEK LOW
1.021
MARKET CAP
24.15M
P/E (TTM)
-0.3972
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IBIO last week (1111-1115)?
Weekly Report · 5d ago
iBio, Inc. Reports Financial Results for the Quarter Ended September 30, 2024
Press release · 11/13 00:49
iBio GAAP EPS of -$0.46 in-line
Seeking Alpha · 11/12 23:13
iBio Q1 EPS $(0.46) Beats $(0.48) Estimate
Benzinga · 11/12 21:52
iBio reports Q1 EPS (46c), consensus (48c)
TipRanks · 11/12 21:44
Press Release: iBio Reports Fiscal First Quarter 2025 Financial Results
Dow Jones · 11/12 21:05
iBio Reports Fiscal First Quarter 2025 Financial Results
Barchart · 11/12 15:05
Weekly Report: what happened at IBIO last week (1104-1108)?
Weekly Report · 11/11 09:42
More
About IBIO
iBio, Inc. is a preclinical stage biotechnology company that leverages artificial intelligence (AI) for the development of precision antibodies. The Company develops biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard-to-target cancers and other diseases. Its StableHu technology is an AI-based tool designed to predict a library of antibodies with fully human Complementarity-Determining Region (CDR) variants based on an input antibody. Its pre-clinical pipeline of immuno-oncology targets the treatment of solid tumors, glioblastoma, head, and neck cancers. Its pipeline includes IBIO-101, TROP-2 x CD3, MUC16, EGFRvIII, CCR8, and Target 5. IBIO-101 is an anti-CD25 monoclonal antibody (mAb) that has demonstrated in preclinical models of disease the ability to bind and deplete immunosuppressive regulatory T (Treg) cells to inhibit the growth of solid tumors.

Webull offers Ibio Inc stock information, including AMEX: IBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IBIO stock methods without spending real money on the virtual paper trading platform.